Ceftazidime 6gm Inj, 1 Vial
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is administered either as an injection into a muscle or as an infusion into a vein over a period of time. In some cases, it may be given as an injection directly into a vein.
Storing and Disposing of Your Medication
If you need to store this medication at home, consult with your doctor, nurse, or pharmacist for guidance on proper storage.
Missing a Dose
If you miss a dose, contact your doctor to determine the best course of action.
Lifestyle & Tips
- Complete the full course of treatment as prescribed, even if you start feeling better. Stopping early can lead to resistant bacteria.
- Stay well-hydrated unless otherwise advised by your doctor.
- Report any new or worsening symptoms to your healthcare provider immediately.
Available Forms & Alternatives
Available Strengths:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of a severe skin reaction (Stevens-Johnson syndrome/toxic epidermal necrolysis), such as:
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Red or irritated eyes
+ Sores in the mouth, throat, nose, or eyes
Dark urine or yellow skin and eyes
Difficulty urinating or changes in urine output
Fever, chills, or sore throat
Unexplained bruising or bleeding
Feeling extremely tired or weak
Redness or white patches in the mouth or throat
Vaginal itching or discharge
Severe diarrhea (C. diff-associated diarrhea, or CDAD), which may cause:
+ Stomach pain
+ Cramps
+ Loose, watery, or bloody stools
Neurological symptoms, such as:
+ Seizures
+ Confusion
+ Shakiness
+ Muscle twitching
+ Trouble controlling body movements (more common in people with kidney problems)
If you experience any of these symptoms, contact your doctor right away. Your doctor may need to adjust your dosage or provide additional guidance.
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. Common side effects include:
Diarrhea
Upset stomach
Vomiting
Stomach pain
Irritation at the injection site
If you experience any of these side effects or have concerns about other symptoms, contact your doctor for advice. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Signs of a severe allergic reaction: rash, hives, itching, swelling of the face, lips, tongue, or throat, difficulty breathing or swallowing, dizziness.
- Severe or watery diarrhea, especially if it contains blood or mucus, which may occur during or even several months after treatment.
- Unusual bleeding or bruising.
- Seizures or confusion (rare, more likely in patients with kidney problems).
- Signs of a new infection (e.g., fever, sore throat, oral thrush, vaginal yeast infection).
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, any of its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you are currently taking chloramphenicol, as this may interact with the medication.
This is not an exhaustive list of potential interactions. Therefore, it is crucial to discuss all of your medications, including prescription and over-the-counter drugs, natural products, and vitamins, with your doctor and pharmacist. This will help ensure that it is safe to take this medication in conjunction with your other medications and health conditions.
Remember, do not start, stop, or modify the dosage of any medication without first consulting your doctor to confirm that it is safe to do so.
Precautions & Cautions
If you have diabetes and regularly test your urine for glucose, consult with your doctor to determine the most suitable testing method, as this medication may affect the accuracy of certain tests. Additionally, be sure to notify all your healthcare providers and laboratory personnel that you are taking this medication, as it may interfere with the results of some lab tests.
Do not take this medication for longer than prescribed, as this can increase the risk of developing a second infection. Older adults (65 years and older) should exercise caution when taking this medication, as they may be more susceptible to side effects.
If you are pregnant, planning to become pregnant, or breastfeeding, it is crucial to discuss the potential benefits and risks of this medication with your doctor to ensure the best possible outcome for you and your baby.
Overdose Information
Overdose Symptoms:
- Seizures
- Encephalopathy (confusion, altered consciousness)
- Neuromuscular excitability
- Asterixis
What to Do:
In case of suspected overdose, seek immediate medical attention or call a poison control center (e.g., 1-800-222-1222). Hemodialysis may be useful in removing ceftazidime from the body, especially in patients with impaired renal function.
Drug Interactions
Major Interactions
- Aminoglycosides (increased risk of nephrotoxicity)
- Loop diuretics (increased risk of nephrotoxicity with aminoglycosides)
Moderate Interactions
- Probenecid (decreased renal tubular secretion of ceftazidime, leading to increased and prolonged plasma concentrations)
- Oral anticoagulants (e.g., warfarin - potential for increased INR/bleeding risk, though less common than with other cephalosporins)
- Live bacterial vaccines (e.g., typhoid vaccine - antibiotics may reduce therapeutic effect)
Monitoring
Baseline Monitoring
Rationale: Ceftazidime is primarily renally eliminated; dose adjustment is required in renal impairment.
Timing: Prior to initiation of therapy
Rationale: To confirm the causative organism and its susceptibility to ceftazidime.
Timing: Prior to initiation of therapy
Routine Monitoring
Frequency: Periodically, especially in patients with pre-existing renal impairment or those receiving concomitant nephrotoxic drugs
Target: Within normal limits or stable for patient's baseline
Action Threshold: Significant increase in creatinine or BUN; consider dose adjustment or alternative therapy
Frequency: Daily
Target: Resolution of signs/symptoms of infection
Action Threshold: Lack of improvement or worsening of infection; consider re-evaluation of diagnosis, susceptibility, or alternative therapy
Frequency: Periodically, especially with prolonged therapy
Target: Within normal limits
Action Threshold: Significant changes (e.g., eosinophilia, leukopenia, thrombocytopenia); may indicate drug-induced hematologic effects
Frequency: Periodically, especially with prolonged therapy
Target: Within normal limits
Action Threshold: Significant elevation; may indicate drug-induced hepatotoxicity (rare)
Symptom Monitoring
- Signs of allergic reaction (rash, itching, hives, swelling of face/lips/tongue, difficulty breathing)
- Severe or persistent diarrhea (may indicate Clostridioides difficile-associated diarrhea)
- Seizures or other central nervous system effects (especially in patients with renal impairment not adequately dosed)
- Signs of superinfection (new fever, persistent sore throat, oral thrush, vaginal yeast infection)
- Injection site reactions (pain, inflammation, phlebitis)
Special Patient Groups
Pregnancy
Ceftazidime is classified as Pregnancy Category B. Animal reproduction studies have not demonstrated a risk to the fetus, but there are no adequate and well-controlled studies in pregnant women. It should be used during pregnancy only if clearly needed.
Trimester-Specific Risks:
Lactation
Ceftazidime is excreted in human milk in low concentrations. It is generally considered compatible with breastfeeding. Monitor the infant for potential adverse effects such as diarrhea, candidiasis (thrush, diaper rash), or allergic reactions.
Pediatric Use
Dosing must be carefully calculated based on weight and age, especially in neonates and infants. Renal function should be monitored, as neonates and young infants have immature renal function. Safety and efficacy are established for various infections.
Geriatric Use
No specific dose adjustment is needed based solely on age, but elderly patients are more likely to have decreased renal function, which necessitates dose adjustment based on creatinine clearance. Monitor renal function closely.
Clinical Information
Clinical Pearls
- Ceftazidime has excellent activity against Pseudomonas aeruginosa, making it a crucial agent for suspected or confirmed pseudomonal infections.
- It has good CNS penetration, making it suitable for treating bacterial meningitis caused by susceptible organisms.
- Always adjust the dose in patients with renal impairment to prevent accumulation and potential neurotoxicity (e.g., seizures).
- Ceftazidime is often used empirically in febrile neutropenia due to its broad-spectrum activity against Gram-negative bacteria, including Pseudomonas.
- While generally well-tolerated, monitor for C. difficile-associated diarrhea, which can occur during or after therapy.
Alternative Therapies
- Other anti-pseudomonal beta-lactams (e.g., Piperacillin/Tazobactam, Cefepime, Meropenem, Imipenem/Cilastatin, Doripenem)
- Aminoglycosides (e.g., Gentamicin, Tobramycin, Amikacin - often used in combination with beta-lactams for severe pseudomonal infections)
- Fluoroquinolones (e.g., Ciprofloxacin, Levofloxacin - for susceptible infections)
- Polymyxins (e.g., Colistin, Polymyxin B - for highly resistant Gram-negative infections)